Legato Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Legato Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,632	Closed	-$1.76M	–	823
2025 Q3	$1.76M	Hold	3,632	–	–	0.19%	158
2025 Q2	$1.47M	Buy	3,632 +650	+22%	+$272K	0.18%	177
2025 Q1	$1.48M	Hold	2,982	–	–	0.2%	161
2024 Q4	$1.55M	Sell	2,982 -636	-18%	-$350K	0.2%	163
2024 Q3	$2.24M	Hold	3,618	–	–	0.28%	100
2024 Q2	$2M	Sell	3,618 -310	-8%	-$178K	0.27%	110
2024 Q1	$2.28M	Hold	3,928	–	–	0.28%	106
2023 Q4	$2.08M	Hold	3,928	–	–	0.27%	111
2023 Q3	$1.99M	Hold	3,928	–	–	0.29%	97
2023 Q2	$2.05M	Buy	3,928 +1,639	+72%	+$884K	0.28%	105
2023 Q1	$1.32M	Hold	2,289	–	–	0.24%	139
2022 Q4	$1.26M	Buy	+2,289	New	+$1.21M	0.24%	133
2021 Q3	–	Sell	-2,289	Closed	-$1.16M	–	311
2021 Q2	$1.16M	Buy	+2,289	New	+$1.08M	0.16%	139
2020 Q3	–	Sell	-5,280	Closed	-$1.91M	–	230
2020 Q2	$1.91M	Buy	+5,280	New	+$1.77M	0.39%	64

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Legato Capital Management's TMO Position: Q4 2025 in Review

Legato Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 3,632 shares — an estimated $1.76M sold.

Legato Capital Management first reported a position in TMO in Q2 2020 and held it in 14 quarters. The position peaked at $2.28M in Q1 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Legato Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
Legato Capital Management sold 3,632 Thermo Fisher Scientific shares in Q4 2025, an estimated $1.76M.
Legato Capital Management first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 14 quarters.
Legato Capital Management's Thermo Fisher Scientific position peaked at $2.28M in Q1 2024.
2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Legato Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.